Physician profile
Alok Goyal
NPI 1003848805
$1,221.86
in general payments reported to CMS, 2019-2025
17 companies · $352 in 2025
The $352 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.82 · 2020: $14.49 · 2021: $186 · 2022: $197 · 2023: $209 · 2024: $232 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $761 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $760.97 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $226.60 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $188.35 | 2019-2024 | Zepbound, Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $163.84 | 2022-2024 | |
| Phathom Pharmaceuticals, INC. | $125.00 | 2025 | Voquezna |
| Abbvie INC. | $125.00 | 2023 | |
| Abbott Laboratories | $71.92 | 2023-2025 | Freestyle Libre 3 |
| Dexcom, INC. | $49.24 | 2023-2025 | Dexcom G6 Transmitter |
| Baxter Healthcare | $41.33 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Pfizer INC. | $41.03 | 2021-2024 | |
| Astrazeneca Pharmaceuticals Lp | $37.77 | 2025 | Farxiga, Breztri |
| Hologic Sales and Service, LLC | $30.85 | 2024 | Aptima |
| Madrigal Pharmaceuticals | $30.45 | 2024 | Resmetirom |
| Insulet Corporation | $26.99 | 2025 | Omnipod |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.45 | 2024 | Xifaxan |
| Rayner Intraocular Lenses Limited | $15.95 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $15.19 | 2023 | Trelegy Ellipta |
| Amarin Pharma, INC. | $14.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alok Goyal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.